Activated protein C (APC) exerts endothelial protein C receptor (EPCR)-
Introduction
Activated protein C (APC) exerts neuroprotective effects in a brain focal ischemia model that implies a potential therapeutic role for APC in the central nervous system (CNS) vascular and neurodegenerative disorders. 1 APC reduces organ damage in animal models of sepsis and of ischemic injury, including stroke, and significantly reduces mortality in patients with severe sepsis. [2] [3] [4] Prospective epidemiologic data suggest that plasma protein C levels are inversely related to incidence of ischemic stroke. 5 APC exerts direct effects on human umbilical vein endothelial cells (HUVECs) via modulation of gene expression that may influence inflammation and apoptosis, 6 and it can trigger intracellular signaling via activation of protease activated receptor-1 (PAR-1) and binding to endothelial protein C receptor (EPCR). 7 It has been suggested that APC down-regulates nuclear factor B-dependent expression of adhesion molecules in HUVECs. 6 PAR-1 and PAR-2 are present on systemic vascular endothelial cells [8] [9] [10] and on brain microvascular endothelium. 11 EPCR is also present on brain endothelial cells 12 where it may augment activation of protein C by the thrombin-thrombomodulin complex, 13, 14 by providing a binding site for protein C on target cell membranes. 7, 12, 15 Recently, it has been shown that both PAR-1 and EPCR are essential for the ability of APC to protect brain endothelium from ischemic injury via down-regulation of p53-dependent proapoptotic pathway. 16 Cleavage and activation of PARs by extracellular proteases, however, are also capable of causing intracellular calcium concentration ([Ca 2ϩ ] i ) signaling. 17, 18 In this study we show that APC induces a potent [Ca 2ϩ ] i signal in the brain endothelium through PAR-1 and that APC binding to EPCR is a prerequisite for this [Ca 2ϩ ] i signal.
Materials and methods

Materials
Purified human plasma-derived APC, protein C zymogen, APC inactivated by heat, and recombinant human mutant Ser360Ala-APC lacking the active serine were prepared as described. 19 No residual thrombin activity was detected in any of the APC preparations.
All [Ca 2ϩ ] i experiments were performed in normal HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid) buffer containing 135 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl 2, 1.2 mM MgCl 2, 10 mM glucose, and 20 mM HEPES. RPMI 1640 was purchased from Cellgro (Herndon, VA). For calcium imaging we used the following antibodies: anti-EPCR RCR-292 and RCR-92, 14 monoclonal antihuman APC-immunoglobulin G (IgG; C3), 20 antihuman PAR-1 (N-19, H-111, and ATAP-2), antihuman PAR-2 (SAM-11), and antihuman PAR-3 (H-103) (Santa Cruz Biotechnology, Santa Cruz, CA). Leech-derived hirudin was obtained from Sigma (St Louis, MO).
Isolation and characterization of human brain microvascular endothelial cells (BECs)
Human brain capillaries were isolated from brain microvascular fragments from autopsies of neurologically healthy young individuals after trauma, and primary human BECs were characterized and cultured as described previously. 21 After fluorescence-activated cell sorter (FACS) analysis using fluorescence-labeled acetylated low-density lipoprotein (Di-ac-LDL, ligand for endothelial scavenger receptor), cells were more than 98% positive for the endothelial markers, factor VIII-related antigen and CD105, and were negative for glial fibrillary acidic protein (GFAP; astrocytes), CD11b (macrophages/microglia), and ␣-actin (smooth muscle cells). Early passage cells were plated on double-coated (polylysine, gelatin) glass coverslips for [Ca 2ϩ ] i measurements.
BEC cultures were kept in RPMI 1640-based medium with HEPES and L-glutamine, containing 20% fetal bovine serum, supplemented with 1% minimal essential medium (MEM) nonessential amino acids, 1% MEM vitamins, 5 U/mL heparin, 30 g/mL endothelial cell growth supplement, 1 mM sodium pyruvate, and 100 U/mL penicillin/streptomycin. Microarray analysis using U95A Affymetrix (Santa Clara, CA) DNA chips on human BECs confirmed the presence of PAR-1, PAR-2, and PAR-3 mRNA as well as EPCR mRNA (Zlokovic et al, unpublished observation, July 2002).
Cell cultures from human umbilical vein endothelium
Primary HUVECs were obtained from ScienCell Research Laboratories (San Diego, CA). Cells were cultured with 17% fetal bovine serumcontaining RPMI 1640 medium. Early passage cultures were used for experiments.
Measurement of [Ca 2؉ ] i in single cells
Cell cultures on polylysine-gelatin-coated glass coverslips were used on the second to third day after seeding when they reached 70% to 90% confluency. The intracellular calcium level of endothelial cells was imaged using a calcium-sensitive fluorescent dye, Fura-2 AM (Teflabs, Austin, TX). BECs and HUVECs were incubated with 4 M Fura-2 AM in RPMI 1640 medium for 40 or 20 minutes, respectively. The coverslips were transferred to a perfusion chamber fitted to a stage of an inverted Nikon Diaphot 300 microscope and superfused with normal HEPES buffer for 15 minutes prior to experiments. All reagents were infused via a multitube perfusion system. [Ca 2ϩ ] i was measured by digital image fluorescence microscopy (objective, Fluor 40/1.3; Nikon) using the Vision 4.0 Software from T.I.L.L. Photonics (Grafelfing, Germany). Excitation wavelengths were 340 and 380 nm, generated by a polychromator illumination system (T.I.L.L. Photonics). Fluorescence emission was monitored at 510 nm. The fluorescent images were collected with a charge-coupled device (CCD) camera (T.I.L.L. Photonics). A fluorescence ratio image (340/380 nm) was acquired in every 2 seconds. The experiments were carried out in HEPES buffer at room temperature (21°C). Fluorescence ratios were converted to free [Ca 2ϩ ] i using the equation described by Grynkiewicz et al. 22 The maximum (R max ) and the minimum (R min ) ratio value and the ratio of fluorescence for Ca 2ϩ -bound/Ca 2ϩ -free dye measured at 380 nm (S f2 /S b2 ) were determined using an in vitro calibration method and were corrected for viscosity. 23 Experimental results are shown as 
Effect of EPCR blockage on APC-induced [Ca 2؉ ] i signal
Two antihuman EPCR antibodies, RCR-252 and RCR-92, were used to study the effect of blocking EPCR on APC-evoked [Ca 2ϩ ] i response. RCR-252 (10 g/mL), an antibody that blocks APC binding to human EPCR, 14 abolished the APC-evoked [Ca 2ϩ ] i response in both BECs and HUVECs (Figure 2Av ,B-C). RCR-92 (10 g/mL), an antibody raised against an epitope on human EPCR distant from the APC binding site, 14 
Discussion
The ability of APC to induce direct cellular responses in endothelial cells 6 may involve distinct signal transduction pathways, such as phosphorylation of mitogen-activated protein kinases (MAPKs). 7 However, little is known about the wide variety of signaling mechanisms that could mediate APC's direct cellular effects. In this study we demonstrate that APC induces an intracellular [Ca 2ϩ ] i signal in human BECs and in HUVECs. [Ca 2ϩ ] i signaling in brain endothelium is of high importance and may lead to changes in cell morphology and blood-brain barrier (BBB) permeability through different mechanisms that include activation of myosin light-chain kinase, and/or conformational and biochemical changes in cytoskeletal proteins comprising the adherens junctions and tight junctions of the BBB. [25] [26] [27] [28] [29] [30] [31] [32] [33] Brown and Davis noted 33 that the exact mechanisms by which calcium flux in brain endothelial cells alters signaling cascades or regulates BBB function are as yet undefined. APC is neuroprotective in vivo 1 and appears to protect stressed brain endothelial cells from hypoxic/ischemic damage in vitro and in vivo, 18 but the implications of the intracellular [Ca 2ϩ ] i signal elicited by APC under physiologic and pathophysiologic conditions remains to be elucidated.
Because APC is generated from protein C by thrombin, we exposed endothelial cells to APC in the presence of hirudin, a highly specific blocker of thrombin. Hirudin did not abolish or reduce the APC-mediated [Ca 2ϩ ] i signals, excluding the possibility that the APC-evoked [Ca 2ϩ ] i was caused by contamination with thrombin. 34 The proteolytic activity of APC was required for its 7, 16 Binding of APC to the endothelial receptor, EPCR is essential for the APC-induced MAPK phosphorylation 7 35 BEC cultures failed to respond to APC when normal endoplasmic reticulum Ca 2ϩ stores had been depleted by thapsigargin, implying that the APC-induced [Ca 2ϩ ] i flux is mobilized initially from the ER Ca 2ϩ stores ( Figure 3B ). Because thapsigargin-induced Ca 2ϩ release activates the 44-kDa and 42-kDa MAP kinases in human fibroblasts and epidermal cells, 26, 36 and, because both MAP kinases are rapidly phosphorylated by APC in HUVECs 7 and human BECs, 37 it is possible that intracellular [Ca 2ϩ ] mobilization by APC from the ER results in rapid activation of MAP kinases by a calcium-dependent pathway. 26, 36 Because of the complexity and multiplicity of the signal transduction mechanisms that potentially contribute to cytoprotection by EPCR-dependent action of APC on PAR-1, 6, 7, 16 future studies on [Ca 2ϩ ] i regulation by APC in various cells are warranted.
In summary, this study shows that human brain microvessel endothelium as well as human umbilical vein endothelium responds to APC with [Ca 2ϩ ] i signaling, where PAR-1 but not PAR-2 and PAR-3 is involved and where APC binding to EPCR is required for this [Ca 2ϩ ] i signaling process.
